Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

TR-1: Standard form for notification of major holdings

December 14, 2018
Download  full announcement   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer  and  to the FCA in Microsoft Word format if possible) i   1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : Renalytix AI Plc 1b.

TR-1: Standard form for notification of major holdings

November 9, 2018
Download  full announcement   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer  and  to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii :   Renalytix AI Plc   (LEI:

TR-1: Standard form for notification of major holdings

November 8, 2018
Download  full announcement NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer  and  to the FCA in Microsoft Word format if possible) i   1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : Renalytix AI PLC 1b.

Director / PDMR shareholding

November 8, 2018
Download  full announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence (“AI”) enabled clinical diagnostic solutions for kidney disease, announces that it was yesterday notified that on 6 November 2018 the following PDMR undertook a transaction in the ordinary shares of

Update regarding AIM admission of RenalytixAI

November 1, 2018
Download  full announcement Renalytix AI plc, which develops artificial intelligence (“ AI ”) enabled clinical decision support solutions for kidney disease, announces that, further to the announcement by EKF Diagnostics Holdings plc  (“EKF”)  on 31 October confirming that RenalytixAI’s had

RENX Pricing announcement

October 11, 2018
THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS DEEMED BY RENALYTIX AI PLC TO CONSTITUTE INSIDE INFORMATION IN RELATION TO THE COMPANY’S QUOTED SECURITIES AS STIPULATED UNDER ARTICLE 7 OF REGULATION (EU) NO. 596/2014. UPON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE,

RENX Launch of Restricted Offer

October 11, 2018
THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY AND RENALYTIX AI PLC TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER ARTICLE 7 OF REGULATION (EU) NO. 596/2014. UPON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO

Update regarding proposed IPO of RenalytixAI

August 31, 2018
Further to the Company’s announcement on 4 July 2018 in relation to Renalytix AI plc (“Renalytix AI”), EKF announces that it intends to undertake further market soundings with institutional and other qualifying potential investors, ahead of a prospective equity Fundraising (defined below) by
Displaying 181 - 190 of 192